IPO registrations (S-1, F-1) · Registrants

MANNKIND CORP

SEC CIK
899460 · filings on EDGAR ↗
Registration
Form S-1, first filed 2004-04-30, last 2017-07-03; 2 initial registrations, 5 amendments
Outcome
Final prospectus filed 2004-07-28; declared effective 2006-11-07
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
1 CASPER STREET, Danbury, CT 06810
EIN
13-3607736
Ticker
MNKD (Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
MANNKIND CORP on the corporate pages

Offering terms

Proposed price range
$13.00–$15.00 per share (S-1/A filed 2004-07-27)
Final price
$10.18 per share, below the range (424B4 filed 2004-07-28, an initial public offering)
Shares sold
6,250,000
Gross proceeds
$63,625,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol MNKD
Lead underwriters
UBS; Piper Sandler (1,250,000 shares); Wachovia (729,166 shares); Jefferies (729,166 shares); Harris Nesbitt (729,166 shares)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 16

FiledFormWhat it isName as filedEDGAR
2004-04-30S-1S-1 (registration)MANNKIND CORP0000950148-04-000827 ↗
2004-06-10S-1/AS-1/A (amendment)MANNKIND CORP0000950148-04-000965 ↗
2004-07-06S-1/AS-1/A (amendment)MANNKIND CORP0000950148-04-000972 ↗
2004-07-26S-1/AS-1/A (amendment)MANNKIND CORP0000950129-04-005113 ↗
2004-07-27S-1/AS-1/A (amendment)MANNKIND CORP0000950129-04-005169 ↗
2004-07-27S-1/AS-1/A (amendment)MANNKIND CORP0000950148-04-000982 ↗
2004-07-28S-1MEFS-1MEF (added securities)MANNKIND CORP0000950134-04-010689 ↗
2004-07-28424B4424B4 (final prospectus)MANNKIND CORP0000950148-04-000984 ↗
2006-11-07EFFECTEFFECT (declared effective)MANNKIND CORP9999999995-06-002215 ↗
2007-08-15EFFECTEFFECT (declared effective)MANNKIND CORP9999999995-07-003326 ↗
2010-05-11EFFECTEFFECT (declared effective)MANNKIND CORP9999999995-10-001461 ↗
2012-09-24EFFECTEFFECT (declared effective)MANNKIND CORP9999999995-12-002804 ↗
2016-04-27EFFECTEFFECT (declared effective)MANNKIND CORP9999999995-16-004350 ↗
2017-07-03S-1S-1 (registration)MANNKIND CORP0001193125-17-220382 ↗
2017-07-14EFFECTEFFECT (declared effective)MANNKIND CORP9999999995-17-001827 ↗
2019-04-05EFFECTEFFECT (declared effective)MANNKIND CORP9999999995-19-000628 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2004-07-27S-1/Aregistration statement$13.00–$15.005,500,000-Nasdaq MNKD6primary document; range, shares headline, underwriting table 1, cover names 5document ↗
2004-07-28424B4final prospectus$10.186,250,000$63,625,000Nasdaq MNKD5primary document; price line, shares headline, proceeds computed, underwriting table 4, cover names 5document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Thomson DavidOfficerCorp VP & General Counsel; EVP Genl Counsel & Secretary; VP & General Counsel1202006–2026
ANDERSON RICHARD LOfficerCorporate VP; VP & CFO122006–2008
Cheatham W WendellOfficerVP, Chief Medical Officer12006
Edstrom HakanDirector,OfficerPresident & CEO; President & COO552006–2015
MANN ALFRED EDirector,OfficerOther; OfficerOtherChairman & CEO; Executive Chairman372006–2015person page Fuzzy
Burns DanOfficerVP & President, MKBP22006
Martens JuergenOfficerCorporate VP; Corporate VP and COO672006–2015
Palumbo DianeOfficerVice President, Human Resource622006–2015
Connell KathleenDirector12006
Consiglio Ronald JDirector262006–2026
Friedman Michael ADirector222006–2026
Keltner LlewDirector12006
KRESA KENTDirector252006–2024
MacCallum DavidDirector162006–2018
NORDHOFF HENRY LDirector162006–2019
Richardson Peter COfficerChief Scientific Officer182006–2012
Murren Heather HayDirector42007–2008
COHEN ABRAHAM EDirector142007–2012
Riesenberger John R.OfficerVP & Chief Commercial Officer42008
PFEFFER MATTHEW JDirector; OfficerCEO, CFO, Director; Corporate VP and CFO412008–2017
Shannon James SamuelDirector202010–2026
Adreveno Linda AOfficer; OtherSr. VP, HR22015–2016
Kocinsky JosephOfficerChief Technology Officer; Corp VP, CTO; CTO182015–2022
Urbanski Raymond W.OfficerCMO; Corp VP, CMO32015–2017
Alinaya Rosabel RealicaOfficerSVP, Investor Relations; SVP, Prin Acctg Officer; VP, IR & Treasury152016–2020
Castagna MichaelDirector,Officer; OfficerChief Commercial Officer; Chief Executive Officer772016–2026
Tross Stuart AOfficerChief People & Workpl Officer; Corp VP, Chief People Officer; EVP, Chief People Officer582017–2026
Alfred E. Mann Living TrustTenPercentOwner22017–2018
Mann Group, LLCTenPercentOwner22017–2018
Binder Steven B.Director; OfficerChief Financial Officer; EVP Special Projects482017–2026
McCauley PatrickOfficerChief Commercial Officer132017–2020
Barton CourtneyOfficerChief Compliance Officer; Chief Compl & Privacy Officer92017–2019
Kendall David MOfficerChief Medical Officer122018–2020
Ingram Elizabeth GarrettOfficerChief Marketing Officer62018–2019
MUNDKUR CHRISTINEDirector112019–2026
HOOPER ANTHONY CDirector122020–2026person page Fuzzy
Grancio JenniferDirector102020–2026
Galindo AlejandroOfficerChief Commercial Officer; EVP Endocrine Business Unit182020–2022
Kay SabrinaDirector92020–2026
Singh Sanjay ROfficerEVP Technical Operations132022–2026
Sabella Lauren MOfficerEVP Chief Operating Officer; EVP Operations102023–2025
BLANK BURKHARDOfficerEVP Chief Medical Officer82023–2025
Prentiss Christopher BOfficerChief Financial Officer92024–2026
Marasco DominicOfficerPres, Endocrine Business Unit62025–2026
Ahuja AjayOfficerChief Medical Officer32025–2026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationMannKind CorporationCTState business registriesname and state
Business registrationMANNKIND CORPORATIONCTState business registriesname and state
Business registrationMANNKIND CORPORATIONCTState business registriesname and state
Business registrationMANNKIND CORPORATIONCTState business registriesname and state
Lobbying clientMANNKIND CORPORATIONCTFederal lobbying (LDA)name and state
SEC filerMANNKIND CORPSEC filers (EDGAR)CIK (EXACT)
Trademark ownerMannKind CorporationCTTrademarks (USPTO)name and state
Form 5500 plan sponsorMANNKIND CORPORATIONEIN (EXACT)
Person pageAlfred E MannPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,OfficerOther)
Person pageAnthony C HooperPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, CT first:

More with this interest.

In other datasets, the same topic (Health) in CT:

Interests: Pharmaceutical Preparations · Health